Institut de Cancérologie de Lorraine

Quick facts

Marketed products

• Adjuvant chemotherapy · Oncology
  Adjuvant chemotherapy uses cytotoxic drugs administered after primary cancer treatment to eliminate residual cancer cells and reduce recurrence risk.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Institut de Cancérologie de Lorraine portfolio CI brief
• Institut de Cancérologie de Lorraine pipeline updates RSS